MINDPAX and EVERSANA announce U.S. commercialization partnership14. October 2021
Mindpax is thrilled to announce recently developed collaboration with life sciences commercial services company EVERSANA.
EVERSANA is a leading provider of commercializing solutions for many health companies, including top 25 U.S. biopharma companies. The all-embracing agreement between Mindpax and EVERSANA covers U.S. market access, including FDI certification, market distribution and commercialization, growth acceleration, as well as patient onboarding. The partnership duration is agreed on eight years and advances MINDPAX in speeding up the neuroscience revolution.